Skip to content

KINESITHERAPIE MUYLDERMANS

Active
Private limited companyfounded 20233 yrs activeSterrebos 67, 3512 Hasselt, BelgiumKBO/BCE: BE 0801.884.647

KINESITHERAPIE MUYLDERMANS has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €46k and a net result of €16k. Equity is growing by ~54.7% per year across the filed fiscal years. Its solvency ranks better than 58% of 16459 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2025
85 / 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability99▼-1
Solvency96▲+8
Growth78=
Track record94
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €3.5k at 30 days acceptable
Liquidity ample (current ratio 1.85 against 1.94 in 2024; short-term debt: 28.9% and cash: 2.5% of total assets), and 28.9% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 3 years 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
71.1%
Return on assets
24.2%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-08-2026, 28 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 3 filings
Deviation from the deadline
2025
28 d late
2024
23 d late
2023
25 d late
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
19-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€46k▲ 51.5%
2024 · €30k
2023: €13k 2024: €30k
2023 → 2025
Total assets
€64k▲ 34.5%
2024 · €48k
2023: €26k 2024: €48k
2023 → 2025
Net result
€16k▼ 11.0%
2024 · €17k
2023: €10k 2024: €17k
2023 → 2025
Working capital
€16k▼ 5.0%
2024 · €17k
2023: €9k 2024: €17k
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line202320242025Trend
Equity€13k-€30k▲ 137%€46k▲ 51.5%
Operating result€15k-€26k▲ 74.8%€22k▼ 14.2%
Net result€10k-€17k▲ 79.4%€16k▼ 11.0%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€10k€20k€30kOperating result 2023: €15k€15kNet result 2023: €10k€10kOperating result 2024: €26k€26kNet result 2024: €17k€17kOperating result 2025: €22k€22kNet result 2025: €16k€16k202320242025
The operating result falls in 2025; 2025 is 14% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €64k
Fixed assets €30k▲ 121%
Current assets €34k▲ 0.4%
Equity and liabilities €64k
Equity €46k▲ 51.5%
Debt €19k▲ 5.5%
The debt ratio falls from 36.8% to 28.9%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€26k
2024 · €28k
Cash flow
€19k
2024 · €19k
Solvency
71.1%
2024 · 63.2%
Current ratio
1.85
2024 · 1.94
Quick ratio
1.85
2024 · 1.94
Debt / equity
0.41
2024 · 0.58
ROE
34.0%
2024 · 57.8%
ROA
24.2%
2024 · 36.5%
Interest coverage
17.17
2024 · 14.62
Debt
€19k
2024 · €18k
Debt ≤ 1 year
€19k
2024 · €18k
Income taxes
€5k
2024 · €7k
Staff costs
€65
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€48k€64k
Fixed assets21/28€14k€30k
Tangible fixed assets22/27€14k€30k
Land and buildings22€11k€29k
Plant, machinery and equipment23€728€198
Furniture and vehicles24€1k€534
Current assets29/58€34k€34k
Amounts receivable within one year40/41€34k€32k
Trade receivables40€34k€32k
Cash at bank and in hand54/58€59€2k
Deferred charges and accrued income490/1€452€938
Equity and liabilities
Total equity and liabilities10/49€48k€64k
Equity10/15€30k€46k
Contributions10/11€3k€3k=
Reserves13€27k€43k
Distributable reserves133€27k€43k
Amounts payable17/49€18k€19k
Amounts payable within one year42/48€18k€19k
Trade debts44€2k€1k
Suppliers440/4€2k€1k
Taxes, remuneration and social security45€15k€16k
Taxes450/3€15k€16k
Other amounts payable47/48€764€2k
Income statement Code20242025
Remuneration, social security and pensions62-€65
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2k€3k
Other operating charges640/8€3k€2k
Gross operating margin9900€31k€27k
Operating profit (loss)9901€26k€22k
Financial income75/76B€0€0
Recurring financial income75€0€0
Financial charges65/66B€2k€2k
Recurring financial charges65€2k€2k
Profit (loss) for the period before taxes9903€24k€21k
Income taxes67/77€7k€5k
Profit (loss) for the period9904€17k€16k
Profit (loss) for the period to be appropriated9905€17k€16k
Appropriation of the result
Profit (loss) to be appropriated9906€17k€16k
Transfer to equity691/2€17k€16k
To other reserves6921€17k€16k

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
28-08
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 28 days late
2025
23-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 23 days late
2024
31-12
Financial Highest result since 2023net €17k ▲79.4%
Operating result €26k, net result €17k, both a record.
25-08
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 25 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Hasselt · 1 establishment unit since 2023
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Sterrebos 673512 Hasselt
Ground area
1,292 m²
Building footprint
776 m²
Volume, LiDAR
7,776 m³
2 parcels, Flanders · tallest building 16.1 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
KINESITHERAPIE MUYLDERMANS
Oude Kuringerbaan 41, 3500 HasseltHuman health activities
since 20232.345.324.495
2 parcels
Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
71327G0617/00M005 Flanders 654 m² 1 · 576 m² 16.1 m · 4 fl.
71055B0481/00X000 Flanders 638 m² 1 · 200 m² 7.1 m · 1 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Public money · subsidies and aid

Flemish government

2025 · 1 entry · 770 EUR awarded · 770 EUR paid
Year Entries awardedpaid
2025 1 770 EUR770 EUR
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
1 entry · 770 EUR · 770 EUR paid · Fonds voor Innoveren en Ondernemen

Similar companies · same sector, comparable size

Of 12,690 companies in sector 86951 we hold annual accounts for 2,140. 1,950 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded17-05-2023
Fiscal year end31-12
Activities, NACEBEL
86905Human health activities
86951Physiotherapy
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers

Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.